Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS

Accenture ( ACN) estimates raised at UBS through 2011. F12 revenue and EPS guidance likely to be maintained. Maintain $64 price target and Buy rating.

Adobe Systems ( ADBE) estimates, target increased at Citigroup.Shares of ADBE now seen reaching $34. Estimates also raised as underappreciated secular value.

AthenaHealth ( ATHN) downgraded at JP Morgan from Neutral to Underweight. Valuation call, based on a $50 price target.

Bed, Bath & Beyond ( BBBY - Get Report) estimates raised at Sterne Agee through 2012. Company is cutting operating costs. Neutral rating.

Boston Scientific ( BSX - Get Report) rated new Hold at Kaufman. $7 price target. Company has still yet to show meaningful sales and earnings growth.

Bristol-Myers ( BMY - Get Report) upgraded at Goldman from Neutral to Buy. $37 price target. Company has the best long-term earnings visibility in the group.

Broadcom ( BRCM) upgraded at JMP to Market Perform. Industry checks suggest better sales prospects.

Conagra Foods ( CAG) rated new Hold at Jefferies. $25 price target. Visibility is cloudy, given the failed RAH bid.

Cubist Pharmaceuticals ( CBST) upgraded at BofA/Merrill to Buy. $45 price target. Cubicin recently received a patent extension.

CVS Caremark ( CVS) rated new Hold at Deutsche Bank. Valuation call, based on a $38.50 price target.

Deckers Outdoor ( DECK) rated new Buy at Auriga. $115 price target. Earnings expectations appear conservative for the near-term.

Diamond Foods ( DMND) downgraded at Jefferies to Hold. Valuation call, based on a $94 price target.

Dollar General ( DG) rated new Buy at Guggenheim. $44 price target. Company should continue to expand its margins over the next several quarters.

Edwards Lifesciences ( EW) target upped at Jefferies to $94. Company can generate significant earnings growth over the next few years.

Family Dollar ( FDO) rated new Buy at Guggenheim. Company should continue to deliver solid growth and generate steady cash flow. $62 price target.

Hershey ( HSY - Get Report) rated new Hold at Jefferies. Valuation call, based on a $58 price target.

HJ Heinz ( HNZ) rated new Buy at Jefferies. $59 price target. Company is leveraged to emerging market growth.

Hologic ( HOLX) rated new Buy at Kaufman Bros. $19 price target. New products should help drive growth in the coming quarters.

Intel ( INTC - Get Report) upgraded at BofA/Merrill to Buy. $27 price target. Estimates also boosted, as the company is seeing margin expansion.

Intuit ( INTU) target boosted at Jefferies to $55. Company can deliver double-digit organic annual sales growth in the coming years. Buy rating.

Johnson & Johnson ( JNJ - Get Report) downgraded at Goldman from Buy to Neutral. Valuation call, based on a $74 price target.

Las Vegas Sands ( LVS) estimates, target increased at Citigroup.Shares of LVS now seen reaching $59. Estimates also raised to reflect GGR trends and improved VIP outlook. Buy rating.

Lennar ( LEN) upgraded at Citigroup from Hold to Buy. $22 price target. Attractive valuation and seasonal homebuilder benefits.

Lululemon Athletica ( LULU) rated new Buy at Argus Research. $75 price target. Company can continue to deliver 30% annual sales growth.

Mako Surgical ( MAKO) cut from Conviction Buy List at Goldman Sachs. Valuation call, based on a $44 price target.

Netflix ( NFLX) upgraded at UBS from Sell to Neutral. $130 price target. Valuation at more reasonable level after correction.

New York Times ( NYT) estimates, target lowered at UBS.Shares of NYT now seen reaching $7. Estimates also lowered on weaker than expected 3Q guidance. Neutral rating.

Red Hat ( RHT) estimates, target raised at Citigroup.Shares of RHT now seen reaching $48. Estimates also increased on higher guidance. Buy rating.

Red Hat estimates increased at Morgan Stanley through 2013. Billings growth is accelerating. Overweight rating and $50 price target.

Red Hat estimates increased at UBS through 2013. Strength across all metrics. Maintain $54 price target and Buy rating.

Salesforce.com ( CRM - Get Report) estimates cut at Jefferies through 2012. Assistly acquisition will dilute near-term earnings. Buy rating and $156 price target.

St. Jude ( STJ) rated new Buy at Kaufman, $50 price target. Company is taking market share, but overall business growth is slowing.

Stryker ( SYK) rated new Buy at Kaufman. $57 price target. Company has multiple growth drivers and should continue to generate solid cash flow.

Tesla Motors ( TSLA) rated new Outperform at Baird. $35 price target. Company continues to differentiate itself from the competition.

Walgreens ( WAG) rated new Hold at Deutsche Bank. $38.50 price target. ESRX dispute could continue to hang over the stock.

Yahoo! ( YHOO) upgraded at Stifel from Hold to Buy. $18 price target. Likelihood of a buyout has improved to 80%.

Zimmer ( ZMH) rated new Hold at Kaufman. $57 price target. Orthopedic market has lackluster growth potential.

End of Report

This article was written by a staff member of TheStreet.